Skip to main content
Clinical Trials/DRKS00028152
DRKS00028152CompletedPhase 4

Outpatient remobilization after total knee and hip arthroplasties - AMB-REMOB

udwig Boltzmann Gesellschaft, Ludwig Boltzmann Institute for Rehabilitation Research0 sites100 target enrollmentStarted: March 15, 2022Last updated:
Conditions

Trial Snapshot

Phase
Phase 4
Status
Completed
Sponsor
Enrollment
100

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomized controlled study
Masking
Open (masking not used)

Eligibility Criteria

Ages
55 Years to 80 Years (—)
Sex
All

Inclusion Criteria

  • Planned unilateral knee or hip replacement for gonarthrosis.
  • Relatively painless and symptom-free contralateral lower extremity (no effusion, no load-limiting pain, VAS less than 5)
  • Age between 55 and 80 years
  • Good general health with good exercise capacity (defined by exclusion criteria)
  • Inclusion of men and non-childbearing women (postmenopausal and other reasons, to be confirmed by pregnancy test in case of doubt)

Exclusion Criteria

  • Previous knee or hip arthroplasty
  • Body mass index (BMI) greater than 40
  • Any conditions/states according to fresh leg vein thrombosis (shorter than 3 weeks),
  • Higher degree of joint effusion
  • infection
  • Pre-existing myopathy
  • Relevant neurological diseases with gait disturbance (Polyneuropathies, MB, Parkinson's)
  • Dementia / reduced cognitive abilities
  • Vestibular diseases with vertigo or balance disorders
  • Symptomatic cardiopulmonary disease in the past 6 months
  • Arterial hypertension not or insufficiently controlled by medication
  • Peripheral arterial occlusive disease (pAVK)
  • Malignant diseases
  • Rheumatic diseases and other internal contraindications
  • Other relevant functional impairment of the musculoskeletal system due to previous surgery, injury and degenerative diseases

Investigators

Sponsor
udwig Boltzmann Gesellschaft, Ludwig Boltzmann Institute for Rehabilitation Research

Similar Trials